BIOMAT Database Logo BIOMAT Database Logo

Prostaglandin E1 in primary pulmonary hypertension. 1986

P K Swan, and J Tibballs, and A W Duncan

UI MeSH Term Description Entries
D006976 Hypertension, Pulmonary Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES. Pulmonary Hypertension
D008297 Male Males
D011669 Pulmonary Wedge Pressure The blood pressure as recorded after wedging a CATHETER in a small PULMONARY ARTERY; believed to reflect the PRESSURE in the pulmonary CAPILLARIES. Pulmonary Artery Wedge Pressure,Pulmonary Capillary Wedge Pressure,Pulmonary Venous Wedge Pressure,Wedge Pressure,Pressure, Pulmonary Wedge,Pressures, Pulmonary Wedge,Pulmonary Wedge Pressures,Wedge Pressure, Pulmonary,Wedge Pressures, Pulmonary,Pressure, Wedge,Pressures, Wedge,Wedge Pressures
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003864 Depression, Chemical The decrease in a measurable parameter of a PHYSIOLOGICAL PROCESS, including cellular, microbial, and plant; immunological, cardiovascular, respiratory, reproductive, urinary, digestive, neural, musculoskeletal, ocular, and skin physiological processes; or METABOLIC PROCESS, including enzymatic and other pharmacological processes, by a drug or other chemical. Chemical Depression,Chemical Depressions,Depressions, Chemical
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000527 Alprostadil A potent vasodilator agent that increases peripheral blood flow. PGE1,Prostaglandin E1,Caverject,Edex,Lipo-PGE1,Minprog,Muse,PGE1alpha,Prostaglandin E1alpha,Prostavasin,Prostin VR,Prostine VR,Sugiran,Vasaprostan,Viridal,Lipo PGE1
D014665 Vasodilator Agents Drugs used to cause dilation of the blood vessels. Vasoactive Antagonists,Vasodilator,Vasodilator Agent,Vasodilator Drug,Vasorelaxant,Vasodilator Drugs,Vasodilators,Vasorelaxants,Agent, Vasodilator,Agents, Vasodilator,Antagonists, Vasoactive,Drug, Vasodilator,Drugs, Vasodilator

Related Publications

P K Swan, and J Tibballs, and A W Duncan
Prostaglandin E1 as a screening vasodilator in primary pulmonary hypertension.
October 1987, Chest,
P K Swan, and J Tibballs, and A W Duncan
Prostaglandin E1 in pulmonary hypertension of collagen disease.
September 1987, Critical care medicine,
P K Swan, and J Tibballs, and A W Duncan
Prostaglandin-E1 infusion in persistent pulmonary hypertension of the newborn.
February 2024, Pediatric pulmonology,
P K Swan, and J Tibballs, and A W Duncan
Effects of prostaglandin E1 on pulmonary circulation in patients with pulmonary hypertension.
December 1978, British heart journal,
P K Swan, and J Tibballs, and A W Duncan
Reduction in pulmonary hypertension by prostaglandin E1 in decompensated chronic obstructive pulmonary disease.
January 1982, The American review of respiratory disease,
P K Swan, and J Tibballs, and A W Duncan
Prostaglandin E1 in the pretransplantation period in patients with pulmonary hypertension.
January 1993, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation,
P K Swan, and J Tibballs, and A W Duncan
Prostacyclin and prostaglandin E1 for severe idiopathic pulmonary artery hypertension.
May 1980, Lancet (London, England),
P K Swan, and J Tibballs, and A W Duncan
[The intrapulmonary metabolism of prostaglandin E1 in patients with pulmonary hypertension].
April 1995, Masui. The Japanese journal of anesthesiology,
P K Swan, and J Tibballs, and A W Duncan
[Vasodilation effects of prostaglandin E1 in patients with precapillary pulmonary hypertension].
April 1990, Casopis lekaru ceskych,
P K Swan, and J Tibballs, and A W Duncan
Prostaglandin E1 and intrapulmonary shunt in cardiac surgical patients with pulmonary hypertension.
March 1990, The Annals of thoracic surgery,
Copied contents to your clipboard!